Idera Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Idera Pharmaceuticals patents 11 in total
| Status | Patent |
|---|---|
Application | Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT Filling date: 7 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: TLR9 MODULATORS FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: USE OF A TLR9 AGONIST IN METHODS FOR TREATING COVID-19 Filling date: 7 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT Filling date: 7 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT Filling date: 7 Sep 2025 Issue date: 11 Feb 2021 |
Grant | Utility: Immune modulation with TLR9 agonists for cancer treatment Filling date: 7 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Immune modulation with TLR9 agonists for cancer treatment Filling date: 7 Sep 2025 Issue date: 15 Sep 2020 |
Application | Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT Filling date: 7 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS Filling date: 7 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT Filling date: 7 Sep 2025 Issue date: 20 Feb 2020 |
Grant | Utility: Immune modulation with TLR9 agonists for cancer treatment Filling date: 7 Sep 2025 Issue date: 5 Nov 2019 |
Showing 1 to 11 of 11 patents.